Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors-Reference-Cited by-同舟云学术

Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors

Published:2013-04-26 Issue:6 Volume:22 Page:641-648
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Hebert Paul L.¹²,McBean Alexander Marshall³,O'Connor Heidi³,Frank Barbara³,Good Charles³,Maciejewski Matthew L.⁴⁵

Affiliation:

1. Northwest Center for Outcomes Research in Older Adults; VA Puget Sound Health Care System; Seattle WA USA

2. Department of Health Services; University of Washington; Seattle WA USA

3. Division of Health Policy and Management, School of Public Health; University of Minnesota; Minneapolis MN USA

4. Center for Health Services Research in Primary Care; Durham VA Medical Center; Durham NC USA

5. Division of General Internal Medicine, Department of Medicine; Duke University; Durham NC USA

Funder

Centers for Medicare and Medicaid Services

VA Health Services Research and Development Service (HSR&D) Research Career Scientist Award

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3449/fullpdf

Reference30 articles.

1. An examination of Alzheimer's disease case definitions using Medicare claims and survey data;Lin;Alzheimers Dement,2010

2. Hypertension prevalence and prescribing trends in older US adults: 1999-2004;Aslam;J Clin Hypertens (Greenwich),2010

3. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia;McGuinness;Cochrane Database Syst Rev,2009

4. Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats;Yamada;Brain Res,2010

5. Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease;Dong;FASEB J,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Instrumental variables in real‐world clinical studies of dementia and neurodegenerative disease: Systematic review of the subject‐matter argumentation, falsification test, and study design strategies to justify a valid instrument;Brain and Behavior;2024-01

2. Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer’s disease: A nationwide population-based cohort study;Frontiers in Aging Neuroscience;2023-03-06

3. Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs – Analysis of a national claims database;Seminars in Arthritis and Rheumatism;2022-12

4. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer’s disease: Past, present and future;Ageing Research Reviews;2022-05

5. Effect of Antihypertensive Drugs on Cognition and Behavioral Symptoms of Patients with Alzheimer’s Disease: A Meta-analysis;Current Pharmaceutical Biotechnology;2021-08-03